|
|
| Welcome to the November edition of our newsletter! |
| Bringing you our latest discoveries in high-throughput screening, genomic and cellular analysis, colony selection, and microplate detection. Visit us at: moleculardevices.com |
|
|
|
|
| Accelerate monoclonal antibody discovery to combat COVID-19 |
This article reveals the steps to develop monoclonal antibodies using our clone screening instruments, from clonal selection to cell growth tracking to image-based assurance of monoclonality.
Join Rebecca Kreipke, Ph.D., as she helps scientists fast-track the FDA approval process and accelerate monoclonal antibody discovery to combat COVID-19 and other infectious diseases.
The time from discovery to proof-of-concept trails could be reduced to 5-6 months from a traditional timeline of 10-12 months.
|
|
|
|
|
|
|
| Automated monoclonality assurance in human stem cell (hSC) engineering |
| Join Gargi Roy of AstraZeneca’s Stem Cell Therapy team to explore high throughput human stem cell engineering workflows that automate monoclonality assurance and accelerate research timelines. |
|
|
|
|
|
Learning Objectives
- Understand how the CloneSelect Single-Cell Printer* is an effective tool for single cell isolation of IPSCs and ESCS
- Explore how the combination of CloneSelect Single-Cell Printer and CloneSelect Imager offers confirmation of monoclonality assessments
- Discover how Clonal ESCs and iPSCs isolated by CloneSelect Single-Cell Printer maintain genomic stability and pluripotency for many generations and can be effectively programmed to differentiate into three germ layers and organ specific cell types
*Only available in North America, Mainland China, Hong Kong, Macau, and Taiwan |
|
|
|
|
|
|
| Rapidly quantify compound effects on mitochondrial functions of cancer cell lines |
| Assessment of mitochondrial function is a vital step in preclinical drug safety assessment since mitochondrial dysfunction can be triggered by certain drugs - resulting in adverse effects on cell and tissue health. Learn how the effective use of a highly sensitive cationic fluorescent dye enabled researchers to visualize and analyze mitochondrial membrane potential changes using automated imaging. |
|
|
|
|
|
|
|
|
|
| Use iPSC-derived cardiomyocytes for evaluation of compound effects and potential cardiotoxicity |
CiPA initiative and validation of high-throughput methods to characterize compound effects in human iPSC-derived cardiomyocytes.
- Hear about the CiPA initiative
- Learn how to evaluate compound induced effects on hiPSC-derived cardiomyocytes
- See the features of the FLIPR® Penta system and ScreenWorks® Peak Pro 2 software
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JOIN OUR TEAM |
| Interested in a career with Molecular Devices? Click here to see our latest openings. |
|
|
